This information was published on 2025-09-12T07:14:34 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2585701 (IR 1874708) |
| (220) |
25 Jul 2025
|
| (300) |
US, 28 Jan 2025, 99020576
|
| (511) (510) |
Class 5
Pharmaceuticals and therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, live biotherapeutic products and other therapeutic agents for the treatment and prevention of diseases and medical conditions, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical use. |
| (540) | KINSORDIA |
| (550) | Word |
| (730) |
Vedanta Biosciences, Inc.
|
Find out more about publications on the About page.